Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21507,774,0.97 [0.84-1.12],0.7225408497041685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21513,123,0.99 [0.69-1.42],0.9457068334606252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22856,126,1.09 [0.79-1.48],0.6063421270412767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17025,431,1.06 [0.89-1.27],0.5194235979183446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22804,74,1.07 [0.70-1.63],0.7543866564785583
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22193,69,1.21 [0.84-1.76],0.3101311491496888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23675,73,1.07 [0.70-1.64],0.7498445511067965
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23694,49,1.12 [0.68-1.84],0.6664194665542702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21716,40,0.91 [0.47-1.78],0.7908466409044564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23255,93,1.10 [0.77-1.59],0.5952253150879443
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23221,59,1.01 [0.61-1.66],0.9834682708869298
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23732,57,0.73 [0.38-1.38],0.3341195037050557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23692,92,1.23 [0.90-1.67],0.1887331288241749
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23684,84,1.25 [0.92-1.72],0.1568506551310974
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,23527,43,1.06 [0.61-1.84],0.8444508289221618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22977,325,0.73 [0.56-0.96],0.024578999033647
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22771,119,0.68 [0.43-1.07],0.0959744495757775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22863,211,0.72 [0.51-1.01],0.058746739579432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20578,27,1.26 [0.69-2.32],0.4473388327704658
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20593,42,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20660,109,1.35 [1.04-1.77],0.0255552190071177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20665,114,1.36 [1.05-1.76],0.0204428285395258
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11567,255,1.11 [0.89-1.39],0.3589883774454496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9260,21,0.38 [0.11-1.41],0.1487380759970654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20594,43,0.64 [0.29-1.41],0.2689465057952123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21939,699,1.06 [0.92-1.22],0.3953828098511567
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22847,181,1.00 [0.75-1.34],0.9977261067605068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23379,72,0.98 [0.61-1.56],0.9248515810580532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23799,69,1.15 [0.77-1.73],0.4943050566741924
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,23602,40,0.98 [0.52-1.85],0.9573607407652328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23798,33,1.56 [1.06-2.29],0.0254849466785373
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Stomach,23836,27,1.60 [1.06-2.41],0.0255901029783327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,23573,259,1.04 [0.83-1.31],0.7246630105545208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23778,104,0.92 [0.61-1.37],0.6704056646719736
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23782,79,1.13 [0.77-1.65],0.5386192777900733
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23751,41,0.89 [0.46-1.72],0.7330184268087501
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",23753,41,0.89 [0.46-1.72],0.733005124295866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,23654,202,0.62 [0.44-0.89],0.0103718253848869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23801,91,0.50 [0.28-0.90],0.0206185052194225
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,23716,159,0.87 [0.62-1.22],0.4194120069349131
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of breast,13147,81,1.18 [0.83-1.67],0.3615789524603374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,12857,594,1.07 [0.92-1.24],0.4001104976679276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23000,166,1.10 [0.84-1.44],0.4820046799589409
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22884,300,1.08 [0.88-1.32],0.4747419764731028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22884,300,1.08 [0.88-1.32],0.4747419764731028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21831,304,0.90 [0.70-1.15],0.3869798871261077
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23410,69,1.15 [0.77-1.71],0.4949880433157335
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23618,84,1.28 [0.93-1.75],0.1290254187058186
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20878,606,0.97 [0.82-1.15],0.7063181278250843
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22744,372,1.10 [0.92-1.32],0.2850952187973143
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22264,86,1.13 [0.78-1.62],0.5143667786271315
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23171,50,1.04 [0.60-1.79],0.8929565052085178
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22253,75,1.18 [0.82-1.71],0.3710682010737069
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22456,278,1.09 [0.87-1.37],0.4610246241008749
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22449,271,1.10 [0.87-1.38],0.4372764960876283
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22164,152,1.05 [0.75-1.46],0.7681041726074049
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22168,150,1.04 [0.75-1.46],0.7993631901010654
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20742,470,0.97 [0.80-1.17],0.7258977341947268
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20337,65,1.53 [1.12-2.10],0.0078492436312689
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20706,434,0.88 [0.71-1.09],0.2554862717092809
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20311,39,1.32 [0.84-2.09],0.2265402315306279
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20331,59,0.65 [0.33-1.29],0.2189001185188929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,20668,661,1.03 [0.89-1.20],0.670500444129303
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20268,261,0.79 [0.59-1.07],0.1284495893225868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23473,198,0.79 [0.55-1.12],0.1813572456618947
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23525,144,0.66 [0.42-1.03],0.0689705720692807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22130,68,0.94 [0.57-1.56],0.814724842941967
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23740,68,0.97 [0.59-1.60],0.8991843322039536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20075,68,0.94 [0.57-1.55],0.815418569952555
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,22146,84,0.49 [0.25-0.94],0.0329341669846814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,22096,61,0.92 [0.54-1.57],0.7585444676753843
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20077,70,1.07 [0.71-1.62],0.7323779262506798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20332,325,1.06 [0.87-1.29],0.5791961895423738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression,22344,282,1.07 [0.87-1.33],0.509492250587382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression or dysthymia,20209,246,1.08 [0.86-1.35],0.5120113599785533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20132,125,1.04 [0.75-1.43],0.818985307738573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Other anxiety disorders,22551,57,0.96 [0.56-1.63],0.8720313825471132
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,21213,1266,0.99 [0.89-1.11],0.8723429636718129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19755,154,0.87 [0.62-1.22],0.4237468628712508
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23652,124,0.69 [0.44-1.08],0.1022418843939043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22697,426,1.05 [0.88-1.26],0.6011150888608616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,22419,148,0.87 [0.60-1.24],0.4288149563568048
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,22358,87,0.61 [0.35-1.07],0.0847622568374082
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23517,77,0.66 [0.37-1.17],0.1573416224151571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23414,35,1.16 [0.65-2.06],0.6189238921798035
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,22419,148,1.22 [0.93-1.59],0.1539260132340121
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,113,1.22 [0.90-1.64],0.2020808712302411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22859,530,0.89 [0.74-1.07],0.2306349844866954
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22450,121,0.91 [0.62-1.32],0.6055059288275932
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22614,285,0.88 [0.68-1.13],0.3244741691532613
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23657,76,1.14 [0.78-1.67],0.5061616035432401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,23631,50,1.20 [0.77-1.86],0.4277026137230347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,23459,108,1.26 [0.95-1.67],0.106281202214687
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,274,0.88 [0.68-1.14],0.3481615706384131
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23303,147,0.85 [0.59-1.23],0.3947512887890714
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23235,79,1.00 [0.66-1.52],0.9882428208777876
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23244,88,1.01 [0.68-1.51],0.9595324961931128
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23199,43,0.72 [0.35-1.50],0.384703146198822
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22351,53,1.12 [0.68-1.84],0.6487715613881079
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22457,159,1.13 [0.85-1.50],0.3893700554586047
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23304,106,0.68 [0.42-1.11],0.1237199632372123
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23621,17,0.53 [0.14-2.07],0.3649612756927519
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1510,17,0.57 [0.16-2.08],0.3934689744287344
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22128,17,0.53 [0.14-2.08],0.3669765981550582
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23513,41,1.08 [0.61-1.92],0.7937097940012267
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23494,22,0.69 [0.24-2.02],0.4972425679593283
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23425,82,0.74 [0.44-1.25],0.2555228180839302
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23473,89,1.22 [0.88-1.69],0.2284440970745727
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23722,110,1.22 [0.91-1.64],0.1916827161460182
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23384,83,1.06 [0.72-1.58],0.7569688974953634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18619,1701,1.02 [0.92-1.13],0.7035639089967664
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23560,36,1.57 [1.11-2.23],0.01166316433688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19520,1142,1.00 [0.89-1.13],0.9697861016020652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,19535,1157,1.00 [0.88-1.13],0.9597454124410982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18407,29,1.01 [0.50-2.04],0.9742241473264692
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22549,492,0.96 [0.79-1.15],0.6393682486095327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,22355,298,0.95 [0.75-1.21],0.6782530230873327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23217,117,0.93 [0.63-1.37],0.7132172713631971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23321,221,0.97 [0.74-1.27],0.8156070782297935
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23739,51,1.00 [0.58-1.74],0.9947719866423732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22195,138,0.85 [0.58-1.25],0.4152539269408619
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22417,368,0.95 [0.76-1.18],0.6310676012593297
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23392,75,1.13 [0.77-1.66],0.5345046600940553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23395,158,1.23 [0.96-1.56],0.0962936820509375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23376,59,1.49 [1.11-2.02],0.009001885831717
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23377,60,1.48 [1.09-2.00],0.0117949000708706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18434,56,1.48 [1.09-2.01],0.0130106473707542
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21582,40,1.11 [0.64-1.91],0.7062081681305042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,21608,66,0.99 [0.61-1.60],0.9675094186800378
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16219,80,1.12 [0.77-1.63],0.5479212843664271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16311,172,1.10 [0.84-1.43],0.4979945819407968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,21578,36,1.20 [0.70-2.06],0.502439059326703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21593,51,1.21 [0.77-1.89],0.4121698669078383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23402,109,0.84 [0.54-1.28],0.4133064950277652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23370,97,1.00 [0.67-1.48],0.9857675506449872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23400,73,1.09 [0.72-1.65],0.6700896726967929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23442,63,0.88 [0.51-1.52],0.6570815793422229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23186,44,0.67 [0.30-1.48],0.3232977677867458
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23217,75,1.51 [1.14-1.99],0.0040077896782185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22786,104,1.29 [0.98-1.71],0.0689397838406766
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22769,87,1.38 [1.05-1.82],0.0223914194638587
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23697,84,1.38 [1.04-1.83],0.0266169091752136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,23059,377,1.15 [0.97-1.36],0.1026922147842544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,23208,42,1.01 [0.56-1.81],0.9842441234777118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20173,1686,1.05 [0.96-1.15],0.3090405585500335
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23634,115,1.32 [1.02-1.70],0.0350624780029618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22813,160,1.27 [1.01-1.61],0.0408306237885609
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22788,135,1.21 [0.93-1.59],0.1586991588709302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23296,194,1.02 [0.77-1.34],0.903524224145012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23295,193,1.02 [0.77-1.34],0.8913302704293831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23069,568,0.99 [0.84-1.16],0.8618146611871274
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,22588,87,1.09 [0.75-1.57],0.6601712176386594
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,22595,94,0.91 [0.59-1.39],0.6504545337199592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22862,361,1.07 [0.88-1.29],0.5134129000498456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,22691,190,1.00 [0.76-1.32],0.9972577534960018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13685,41,1.03 [0.56-1.89],0.9272880653301728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21813,767,0.97 [0.84-1.12],0.6744627557689618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,23229,92,0.83 [0.52-1.35],0.4600755719565171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23229,92,0.83 [0.52-1.35],0.4600755719565171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23229,92,0.83 [0.52-1.35],0.4600755719565171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22317,692,0.98 [0.85-1.14],0.8430305877953297
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Asthma,18204,692,0.97 [0.84-1.13],0.7163812314791598
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18075,692,0.97 [0.83-1.13],0.6877319164203359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18189,677,0.98 [0.84-1.14],0.8102952544824863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23668,53,1.39 [0.95-2.01],0.0859574973238462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,22669,41,1.47 [0.99-2.18],0.0557505764247602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23724,41,1.46 [0.98-2.15],0.0601881853736505
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22663,35,1.43 [0.92-2.24],0.1124809272630738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,22672,67,1.07 [0.69-1.66],0.7620770265728021
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,22761,156,1.18 [0.91-1.52],0.2150933139079551
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23101,71,1.29 [0.92-1.82],0.1347544765184324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16926,4434,1.02 [0.95-1.09],0.5777618185915937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23315,419,0.89 [0.73-1.09],0.2718984120807687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23771,119,0.92 [0.64-1.33],0.6565091961490009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,23776,110,0.95 [0.66-1.38],0.7848673449151171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,22997,101,1.12 [0.80-1.57],0.5187793714643918
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22988,92,0.89 [0.57-1.38],0.589168338985054
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23758,133,0.95 [0.68-1.33],0.7562253690160443
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22971,75,0.48 [0.25-0.93],0.0305544997554432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22765,51,0.71 [0.36-1.43],0.3430539428777944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23728,38,0.55 [0.22-1.34],0.1862167460257903
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19167,176,0.99 [0.73-1.35],0.9624026257518706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20515,1524,1.04 [0.95-1.15],0.3918098108375238
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,19224,233,1.12 [0.89-1.41],0.3304541554017858
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19483,492,1.03 [0.87-1.23],0.7313595355942173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19048,57,1.44 [1.02-2.05],0.0384732082548821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19112,121,1.09 [0.79-1.51],0.6051883717420468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19015,24,0.59 [0.20-1.75],0.3400851785300501
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,19077,86,1.02 [0.67-1.55],0.91651971322348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,19082,91,1.13 [0.77-1.66],0.5357768494288462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,64,1.28 [0.87-1.87],0.2057941432699891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,19086,95,0.98 [0.64-1.50],0.9326196970193772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19544,553,1.06 [0.90-1.24],0.4888211932698174
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,23673,138,0.81 [0.55-1.19],0.2787221192077335
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,19334,343,0.96 [0.77-1.19],0.7181134756060108
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19085,94,1.18 [0.85-1.66],0.3228462861371741
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23665,171,0.87 [0.62-1.21],0.3972592528498229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,23643,108,0.94 [0.64-1.39],0.7705905247503185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,21501,1018,1.10 [0.98-1.23],0.118672776418335
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,20820,337,0.98 [0.79-1.22],0.8865299341698916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,20583,100,1.07 [0.74-1.55],0.7010466767960386
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,20558,75,1.06 [0.68-1.63],0.807182086442439
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21016,533,1.15 [0.99-1.34],0.062203502497385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23084,645,1.11 [0.96-1.27],0.1580233657102406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,19614,1437,1.05 [0.95-1.17],0.2986933249428554
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23548,61,0.72 [0.39-1.33],0.2957244317392559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23765,88,0.96 [0.63-1.47],0.8664048193017644
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,22527,88,0.97 [0.64-1.47],0.8890348137680106
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22507,68,1.13 [0.75-1.70],0.5512895263172408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23715,114,1.19 [0.89-1.60],0.241472840045164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,22553,114,1.20 [0.89-1.60],0.2324042496508949
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22536,97,1.24 [0.91-1.68],0.1735728374930472
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22958,519,1.13 [0.97-1.32],0.1036169162936454
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22954,515,1.14 [0.98-1.32],0.0964173133479205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18235,58,1.09 [0.68-1.73],0.7232511850716901
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal stricture,23541,58,1.09 [0.69-1.74],0.7041252553753958
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18219,42,1.20 [0.73-1.94],0.4722266746865685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18438,261,1.21 [1.00-1.47],0.0526859289533404
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18322,145,1.23 [0.96-1.58],0.097771538698074
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18388,211,1.05 [0.82-1.35],0.6986269547165564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,22840,186,1.09 [0.84-1.41],0.5041791697096654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23473,71,0.52 [0.27-1.00],0.0515968966518727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18336,159,0.80 [0.56-1.15],0.2213067360477444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18259,82,0.80 [0.49-1.33],0.3955617025509222
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18864,687,1.04 [0.90-1.20],0.5591392655754364
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,18334,157,0.87 [0.61-1.23],0.4156508616158597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23463,61,0.57 [0.29-1.13],0.1063305620665702
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,23201,105,0.96 [0.65-1.43],0.8567804611047269
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,23156,60,1.12 [0.72-1.75],0.602071754940859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22748,447,0.97 [0.80-1.17],0.7409880583383737
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,22658,357,0.98 [0.79-1.20],0.8344804252388409
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,22362,61,0.48 [0.23-0.99],0.0468069025603438
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22337,36,1.43 [0.97-2.12],0.073574771299534
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,22351,50,0.94 [0.52-1.69],0.8376654167319876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23679,50,0.94 [0.52-1.70],0.8409736735152793
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22747,245,1.00 [0.78-1.28],0.9889934981490204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22560,58,1.53 [1.14-2.06],0.0047040621095831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,22549,47,1.52 [1.08-2.13],0.0151864161085948
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22538,36,0.84 [0.41-1.74],0.6463788774433203
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22658,156,0.77 [0.53-1.13],0.1850417293338468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,22653,151,0.78 [0.53-1.15],0.2165903618183023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21628,1280,1.02 [0.92-1.14],0.7115252850985966
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23503,87,0.92 [0.59-1.43],0.7067870125883816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23475,404,1.16 [0.98-1.37],0.0857122760047911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22881,453,1.07 [0.90-1.27],0.4494305986516596
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23156,354,0.85 [0.67-1.08],0.1844688788599602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22897,95,0.64 [0.37-1.10],0.1068463456292024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23002,200,1.04 [0.79-1.35],0.7974316726271156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23611,72,0.82 [0.48-1.39],0.4546609337606918
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23598,59,0.78 [0.43-1.43],0.4291161950175061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23581,42,0.95 [0.51-1.76],0.8603546426046791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23695,27,0.97 [0.46-2.05],0.9442292606774014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23692,24,0.89 [0.38-2.07],0.7818091103479411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23127,56,1.14 [0.74-1.78],0.5492733950479125
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23379,308,1.19 [0.99-1.43],0.0660907519598868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22487,59,1.17 [0.76-1.80],0.4678108383427497
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22509,81,0.90 [0.56-1.43],0.6534588541418911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22498,70,0.83 [0.49-1.42],0.4991950332928371
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22605,177,0.87 [0.63-1.20],0.3980398962374366
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22583,155,0.94 [0.68-1.31],0.714910826613058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18452,3025,0.96 [0.89-1.04],0.3640542012544219
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19820,1610,0.99 [0.89-1.09],0.8227529606825861
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21717,944,0.88 [0.77-1.02],0.0877887636018916
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18322,112,1.02 [0.71-1.46],0.9237714096302334
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18514,304,1.05 [0.85-1.30],0.6451810928553903
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23543,107,1.05 [0.74-1.51],0.7698091333918495
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23555,95,1.07 [0.73-1.55],0.7408535930834934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18782,572,1.03 [0.88-1.21],0.6866009086214049
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20979,572,1.05 [0.89-1.23],0.5639709450155349
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18249,39,1.14 [0.66-1.95],0.6400847285548208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23503,38,1.18 [0.69-2.00],0.5498469988347972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18341,131,0.97 [0.68-1.37],0.8426532673427465
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18231,21,0.98 [0.40-2.37],0.9563404667811382
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18318,108,1.19 [0.87-1.62],0.2660157167206562
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23730,55,1.23 [0.81-1.87],0.3214818756803081
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18499,289,0.94 [0.74-1.19],0.6127064312735064
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18401,191,1.05 [0.80-1.38],0.699098103149914
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19270,1060,0.92 [0.81-1.05],0.2029844760513076
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18245,35,0.42 [0.16-1.14],0.0884455579758821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18362,152,0.84 [0.59-1.21],0.3534736279896666
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18235,25,0.82 [0.34-2.01],0.6673958237011299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18235,25,0.85 [0.36-2.01],0.7191255262648822
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18654,444,0.87 [0.71-1.07],0.1895051463769967
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18583,373,0.89 [0.71-1.10],0.2750909784741715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18816,240,1.20 [0.97-1.47],0.0932617627499761
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23485,141,1.24 [0.97-1.60],0.0909209396527275
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23380,36,1.60 [1.13-2.26],0.0074310470536237
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21272,44,0.73 [0.35-1.52],0.4068450203742548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21426,198,0.83 [0.60-1.14],0.256423362852141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22015,787,0.91 [0.78-1.06],0.2264751664266481
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21350,122,0.89 [0.60-1.31],0.5489122676561531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21277,49,0.50 [0.23-1.13],0.096767303929767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21888,660,0.94 [0.80-1.10],0.4622110695084809
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21276,48,0.79 [0.41-1.53],0.4842793876670229
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21454,226,0.91 [0.69-1.20],0.5032170782554186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21329,101,0.98 [0.67-1.43],0.8994625593135226
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21286,58,0.79 [0.43-1.44],0.4341535965561075
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21348,120,0.93 [0.64-1.36],0.7133811681701014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21286,58,1.32 [0.92-1.90],0.1296707361077791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21512,284,0.89 [0.69-1.14],0.3521632242674103
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21016,243,0.71 [0.52-0.97],0.0320333341223732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20818,45,0.93 [0.50-1.70],0.8068531673326882
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20816,43,0.77 [0.38-1.57],0.4716650180928677
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20875,102,0.47 [0.26-0.82],0.0084242973706531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20824,51,0.89 [0.49-1.60],0.6871472778911565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20826,53,0.94 [0.54-1.65],0.8400280153614633
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20814,41,0.97 [0.52-1.80],0.9109765837888658
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20958,185,0.96 [0.71-1.29],0.7801604129529909
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20817,44,0.74 [0.36-1.52],0.4072254397748072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20816,43,1.21 [0.74-1.96],0.4483424250772723
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20864,91,0.64 [0.37-1.09],0.1029142980695665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20838,65,0.81 [0.47-1.42],0.4669387576793485
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21149,376,0.97 [0.79-1.19],0.7832616126175577
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20904,131,0.86 [0.59-1.26],0.43778633781811
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20969,196,1.10 [0.86-1.41],0.4511110404532999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22635,92,1.08 [0.74-1.58],0.6993628437540107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22836,293,0.94 [0.74-1.19],0.5906271961866003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22591,48,0.61 [0.29-1.32],0.2097250545715419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22599,56,0.72 [0.38-1.37],0.3217394990285616
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22642,99,0.99 [0.67-1.45],0.9419833120771642
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20181,3780,1.01 [0.94-1.08],0.8764247119535199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9665,343,1.02 [0.83-1.26],0.8486444453896418
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22558,157,1.07 [0.80-1.43],0.6296150705265432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22445,44,1.15 [0.69-1.91],0.6005086175027278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22699,33,0.89 [0.41-1.92],0.7695537283014828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22694,28,1.29 [0.74-2.25],0.3746706449816266
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22705,39,1.29 [0.82-2.01],0.2702995639801216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23518,205,1.17 [0.94-1.47],0.1635835537751236
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23585,44,1.09 [0.63-1.87],0.75941428454313
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23455,142,1.19 [0.91-1.55],0.194231102510583
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23399,86,1.16 [0.81-1.65],0.4217214511190114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22518,762,0.97 [0.84-1.12],0.6965538341972921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,21824,68,0.87 [0.51-1.48],0.6088306243601334
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,1.05 [0.64-1.73],0.836927632982448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21912,156,1.26 [0.99-1.61],0.0634156574593572
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21836,80,1.02 [0.67-1.56],0.9159026577365672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22291,535,0.98 [0.83-1.17],0.8610781204525234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9381,59,0.96 [0.57-1.63],0.8884131995042753
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9355,33,1.17 [0.67-2.06],0.5818961192003937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,9357,35,0.94 [0.47-1.87],0.8540128695495065
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9394,72,1.22 [0.85-1.76],0.2764432651614001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9379,57,1.09 [0.67-1.76],0.7400726795998984
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9402,80,0.99 [0.64-1.54],0.9759672879991748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13024,217,1.04 [0.82-1.33],0.7252257735876133
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12871,64,0.91 [0.54-1.51],0.7053949142268792
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12880,73,1.21 [0.84-1.74],0.3035230344966755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12855,48,0.81 [0.43-1.54],0.5231614639249714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12991,333,0.97 [0.79-1.20],0.776432008219463
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12729,71,0.90 [0.56-1.45],0.6629871906210447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12826,168,1.06 [0.81-1.39],0.6692114244803367
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11988,2391,1.00 [0.92-1.09],0.9920781875863124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,9847,250,0.86 [0.66-1.12],0.258956944200796
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9676,79,0.83 [0.52-1.34],0.4549249124258251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9694,97,0.85 [0.55-1.30],0.4516494274033052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9864,267,1.14 [0.93-1.39],0.2093869898165807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9861,264,0.94 [0.74-1.20],0.6112862939535801
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10011,414,1.05 [0.88-1.25],0.5920262359427007
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9744,147,1.08 [0.81-1.43],0.6062500191916469
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9784,187,1.13 [0.89-1.44],0.3242459821320238
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9668,71,0.80 [0.48-1.35],0.4053749587162114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9722,125,1.10 [0.82-1.48],0.5267326011894129
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13152,175,1.21 [0.96-1.53],0.1030528024813915
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13159,168,1.23 [0.98-1.56],0.0765342758872816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13175,95,1.34 [1.01-1.76],0.0396580457202223
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13169,103,1.30 [0.98-1.71],0.0680017392754094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9657,60,1.27 [0.88-1.84],0.1947290272975044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9650,53,1.03 [0.63-1.69],0.8909811675303525
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9657,60,0.64 [0.34-1.23],0.182976174789581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,13089,321,1.00 [0.81-1.23],0.9889629277748496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10583,986,1.05 [0.94-1.19],0.3852507233070475
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10272,675,1.05 [0.91-1.21],0.534430080886727
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13163,138,1.01 [0.74-1.39],0.936994461866242
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9898,301,1.06 [0.87-1.31],0.5477276984999535
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9823,226,1.13 [0.91-1.40],0.2815725651006149
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9828,231,0.97 [0.74-1.27],0.8196586208380416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female infertility,9684,87,0.79 [0.49-1.26],0.3197867200938449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9677,80,0.83 [0.52-1.33],0.4360485180165471
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13169,723,0.93 [0.79-1.08],0.3310627860869888
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13176,988,0.85 [0.74-0.99],0.0315042640374853
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13171,383,0.89 [0.72-1.10],0.2826040963402757
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12897,109,0.79 [0.51-1.20],0.2692208628745822
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12943,155,0.73 [0.50-1.06],0.0994158282015085
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12922,134,1.20 [0.92-1.57],0.1826955547573719
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13185,139,0.98 [0.72-1.35],0.9222608797823174
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13187,138,0.97 [0.71-1.34],0.8721722935190874
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13184,354,0.84 [0.67-1.06],0.1390148693011171
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12933,103,0.86 [0.58-1.30],0.4840230900115118
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13030,200,0.70 [0.50-0.99],0.044198516716693
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12569,123,1.25 [0.95-1.64],0.1109412216322274
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12614,168,1.19 [0.94-1.52],0.1558205915749815
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12648,202,0.91 [0.68-1.20],0.4944892669929042
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12571,125,0.69 [0.45-1.06],0.0915725445990669
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12561,115,0.84 [0.57-1.25],0.3887415856058933
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12565,119,0.70 [0.46-1.08],0.1109170855965827
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12379,191,0.81 [0.59-1.12],0.2094155323095151
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12550,362,0.86 [0.69-1.08],0.19553874893277
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12738,550,0.84 [0.69-1.01],0.0666507037609279
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13190,143,0.83 [0.58-1.19],0.3101351954666346
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,11990,110,0.76 [0.49-1.17],0.2123081622679068
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12269,81,1.02 [0.69-1.52],0.9124478035774588
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13195,277,0.95 [0.76-1.21],0.6964788264476633
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13133,215,0.81 [0.60-1.09],0.1710748166658837
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13184,208,0.83 [0.61-1.12],0.2144940821011128
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13174,198,0.76 [0.55-1.05],0.1007407595572637
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23619,32,0.92 [0.45-1.91],0.8295984671348577
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22420,446,0.99 [0.82-1.19],0.8966098050786996
